ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Tandem Diabetes Care Inc

Tandem Diabetes Care Inc (TNDM)

42.62
-3.01
(-6.60%)
Closed July 18 4:00PM
42.62
0.00
( 0.00% )
Pre Market: 7:31AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
42.62
Bid
42.51
Ask
43.25
Volume
-
0.00 Day's Range 0.00
13.82 52 Week Range 53.69
Market Cap
Previous Close
42.62
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
1,487,904
Shares Outstanding
64,589,518
Dividend Yield
-
PE Ratio
-12.37
Earnings Per Share (EPS)
-3.45
Revenue
747.72M
Net Profit
-222.61M

About Tandem Diabetes Care Inc

Tandem Diabetes Care Inc is a medical device company that develops products for people with insulin-dependent diabetes. The firm has three key insulin pump products. The t:slim Insulin Delivery System can easily fit into a user's pocket. The t:flex Insulin Delivery System is used by customers with g... Tandem Diabetes Care Inc is a medical device company that develops products for people with insulin-dependent diabetes. The firm has three key insulin pump products. The t:slim Insulin Delivery System can easily fit into a user's pocket. The t:flex Insulin Delivery System is used by customers with greater insulin needs. The t:slim G4 Insulin Delivery system is a continuous glucose monitoring enabled pump with a touch screen. Tandem Diabetes also sells pump-related supplies and accessories. Pump sales contribute the majority of revenue. The firm generates virtually all of its revenue in the United States. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Wilmington, Delaware, USA
Founded
1970
Tandem Diabetes Care Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker TNDM. The last closing price for Tandem Diabetes Care was $42.62. Over the last year, Tandem Diabetes Care shares have traded in a share price range of $ 13.82 to $ 53.69.

Tandem Diabetes Care currently has 64,589,518 shares outstanding. The market capitalization of Tandem Diabetes Care is $2.75 billion. Tandem Diabetes Care has a price to earnings ratio (PE ratio) of -12.37.

Tandem Diabetes Care (TNDM) Options Flow Summary

Overall Flow

Bullish

Net Premium

20k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

TNDM Latest News

Tandem Diabetes Care to Announce Second Quarter 2024 Financial Results on August 1, 2024

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2024 results after the financial markets close on...

Tandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today presented new real-world insights from a survey on Tandem Mobi user satisfaction and...

Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating Officer

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Jean-Claude “JC” Kyrillos as Executive Vice President and...

Tandem Diabetes Care to Present New Early User Insights on the Tandem Mobi System at the American Diabetes Association’s 84th Scientific Sessions

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced its schedule of presentations for the American Diabetes Association’s (ADA...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-2.97-6.5145865321345.5948.2442.4002114729345.82064603CS
4-0.35-0.81452175936742.9748.2438.575135182442.37536708CS
127.2920.634022077635.3353.6934.43148790444.84817271CS
2617.7371.233427079124.8953.6921.85163239435.34846838CS
5210.5833.021223470732.0453.6913.82160072829.50764432CS
156-55.53-56.576668364798.15155.8613.82117697148.92150597CS
260-21.33-33.354182955463.95155.8613.82112534460.32282572CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
HUBCWHub Cyber Security Ltd
$ 0.0345
(94.92%)
62
SERVServe Robotics Inc
$ 4.77
(81.37%)
4.95M
SXTP60 Degrees Pharmaceuticals Inc
$ 0.3317
(34.84%)
6.87M
GNLXGenelux Corporation
$ 2.90
(26.09%)
2
CXAICXApp Inc
$ 2.80
(25.56%)
647
KITTNauticus Robotics Inc
$ 0.102
(-20.87%)
994.18k
SPWRSunPower Corporation
$ 1.24
(-17.88%)
674.53k
MTEMMolecular Templates Inc
$ 1.21
(-15.38%)
1
AZA2Z Smart Technologies Corporation
$ 0.7623
(-14.33%)
173
GDTCCytoMed Therapeutics Ltd
$ 1.97
(-13.98%)
246
SXTP60 Degrees Pharmaceuticals Inc
$ 0.3317
(34.84%)
6.87M
SGDSafe and Green Development Corporation
$ 0.4165
(12.63%)
6.12M
SERVServe Robotics Inc
$ 4.77
(81.37%)
4.95M
SQQQProShares UltraPro Short QQQ
$ 8.19
(-0.49%)
3.3M
MAXNMaxeon Solar Technologies Ltd
$ 0.2298
(-4.41%)
2.64M

TNDM Discussion

View Posts
Trueheart Trueheart 4 years ago
America's appallingly high rate of obesity and resultant diabetes cannot do anything but make this company a winner.

Trueheart
👍️0
Trueheart Trueheart 4 years ago
I'm an investor in DexCom (DXCM) and just found this on the CNBC crawl.

I will investigate the company.

Trueheart
👍️0
TFMG TFMG 4 years ago


$TNDM | #Tandem Bullish on Break Above $100

Alert set for break above $100
Indicators bullish .
$105 First target with confluence of
Fibonacci expansion and extension level.
Strong historical weekly resistance level also.
$116 second target to dead cat bounce Fibonacci .382 level.

PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.


👍️0
TFMG TFMG 4 years ago
$TNDM Tandem Diabetes On Breakout Watch



Alert set for break above $93.00,
Indicators bullish .
$100 first target as key psychological resistance .
$105 second target with confluence of
Fibonacci expansion and extension level.
Strong historical weekly resistance level also.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.


👍️0
The revenant The revenant 4 years ago
Does anyone know why this is trading?
👍️0
whytestocks whytestocks 5 years ago
$TNDM bulls and bears Tandem Diabetes Care Inc Nasdaq Tndm Short Squeeze
👍️0
whytestocks whytestocks 5 years ago
News: $TNDM Tandem Diabetes Care Announces FDA Clearance of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology

Automated Insulin Dosing Software First to Receive New Classification by FDA Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced U.S. Food and Drug Administration (FDA) clearance of the t:slim X2™ insulin pump ...

Read the whole news TNDM - Tandem Diabetes Care Announces FDA Clearance of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology
👍️0
whytestocks whytestocks 5 years ago
News: $TNDM 3 Top Growth Stocks to Buy in the Final Month of Summer

This summer was one of the hottest on record. In fact, July was the hottest month globally since record keeping began 140 years ago. But don't let your melted ice cream derail your quest for wealth. There are still growth stocks out there torching expectations and delivering above-average retu...

Find out more 3 Top Growth Stocks to Buy in the Final Month of Summer
👍️0
TFMG TFMG 5 years ago
Tandem Diabetes Care Inc Has Huge growth potential

Jim Cramer spoke with Kim Blickenstaff, executive chairman at Tandem Diabetes Care ( TNDM ) , which posted strong earnings last week but quickly reversed, Blickenstaff blamed the sudden reversal in their shares on global uncertainty. He said Tandem has no business in China and is in "acceleration mode."
Currently, only 30% of Type 1 diabetes patients are using a pump, Blickenstaff said, leaving a lot of room for growth for Tandem. The market potential is even greater worldwide, especially in Europe as the condition continues to become a epidemic.
The chart remains bullish but maybe more confirmation required before placing a trade.

👍️0
north40000 north40000 5 years ago
Per TNDM 8-k dated 6-09-2019:

Tandem Diabetes Care, Inc. issued a press release announcing results from two studies of the t:slim X2™ insulin pump with Control-IQ™ advanced hybrid closed loop technology. Details from the two studies, which included data from Protocol 3 of the National Institutes of Health (NIH)-funded International Diabetes Closed Loop trial (DCLP3), and interim data from the Freelife Kid AP study, were presented on June 9, 2019 at the 79th Scientific Sessions of the American Diabetes Association.

PODD technology in combination with TNDM pump for young T1-D, said to delay development of T1-D. Very early in clinical trial.

**************************

"Pediatric Scientific Data for the Omnipod Horizon System Presented at the American Diabetes Association’s 79th Scientific Sessions

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced that positive results from the most recent clinical trial of the Omnipod® Horizon™ Automated Insulin Delivery System (Omnipod Horizon System) were presented during the American Diabetes Association (ADA) 79th Scientific Sessions in San Francisco, California. The study demonstrated that the investigational Omnipod Horizon System performed well and was safe for up to four days of use in children as young as two years old with type 1 diabetes.1

The study was conducted in a supervised hotel setting under free-living conditions with unrestricted meals and daily exercise and included pediatric participants between two and six years old. The study was preceded by seven days of their usual therapy at home with continuous glucose monitoring. Study participants spent significantly less time in hyperglycemia (=250 mg/dL), spent significantly more time in the target glucose range (70-180 mg/dL), and had better overnight glycemic control compared to their usual therapy, which is in line with the positive performance observed in earlier studies including older pediatric, adolescent and adult study participants. During the study, glucose control was maintained in the target range for 73% of the time overall and 85% of the time during the overnight period. The percentage of time spent in the hypoglycemic range (<70 mg/dL) was very low, at 2.9% overall and 2.0% overnight. The investigational Omnipod Horizon System includes unique features that allow diabetes management to be customized by adjusting the target blood glucose levels and insulin delivery....[more]
👍️0
ALL-IN888 ALL-IN888 5 years ago
Another Diabetes Drug Exploding on News: LXRX get in now will still cheap Analyst Price Target @ $34.00 BOOM $$$
👍️0
modrica modrica 5 years ago
Net loss 22 millions , book value $2 , market cap 4 billions , something doesn't add up , oh well
👍️0
stocktrademan stocktrademan 5 years ago
TNDM buy 62.73



normal chart







log chart






👍️0
ALL-IN888 ALL-IN888 5 years ago
Exploding Back to 70.00's Next week, Go Full Blast Buying now or cry!!! $$$$$ BOOM
👍️0
ALL-IN888 ALL-IN888 5 years ago
Going Green Today!!! Nice Catch from 51.50 Used to trade this stock from 3.00 Holy Karamba!! LOL
👍️0
ALL-IN888 ALL-IN888 5 years ago
WOW! ALL IN @ 51.50 BOOM Lets Going back to 74.00 Very Soon!!! $$$$$
👍️0
ITMS ITMS 5 years ago
Tandem Diabetes Care Inc $TNDM Retreats, Watch This Trade Level

Tandem Diabetes Care Inc (NASDAQ:TNDM), is a leading manufacturer and developer of medical devices for people with insulin dependent diabetes using its micro-delivery technology. The stock has been pulling back since March 22, 2019 when it traded as high $74.77 a share. Since that recent pivot top, the stock has pulled back and is now trading at $60.33 a share. Traders and investors should note the gap fill window around the $50.00 level on a daily chart. This level should be solid support. There was sideways consolidation around the $50.00 area before the gap higher breakout move in late February 2019 making this a good support level when tested. At this time, the company is scheduled to report earnings on April 25, 2019.




Nick Santiago
InTheMoneyStocks
👍️0
PeaceMann PeaceMann 5 years ago
Tandem Diabetes is on a roll

I can't wait for Vdex Diabetes of Ohio Akron to open.
Vdex Diabetes of Ohio Akron
👍️0
make it happen make it happen 5 years ago
added 1,200 share short today
👍️0
modrica modrica 5 years ago
Net loss for a year 2018 is 122 millions $ , market cap over 3 billions , something doesn't add up , imo
👍️0
Alan Brown Alan Brown 5 years ago
Yep.
👍️0
make it happen make it happen 6 years ago
Agreed. Also insiders dumping like crazy most barely even have a position in the company now lol
👍️0
modrica modrica 6 years ago
Revenues 46 millions , net loss 34 millions , market cap 2,4 billions !!!

Something doesn't add up
👍️0
stocktrademan stocktrademan 6 years ago
TNDM buy 43.62























normal chart




log chart



👍️0
4on4off 4on4off 6 years ago
Buying the dip. $TNDM
👍️0
mcrouch mcrouch 6 years ago
What's up with the 15% drop today?? Not seeing anything in the news that would trigger this.
👍️0
crudeoil24 crudeoil24 6 years ago
Made nice profits > I am a day trader
👍️0
BAD HEMPER BAD HEMPER 6 years ago
Wooo Hooo!! $50 next stop :)
👍️0
crudeoil24 crudeoil24 6 years ago
May be shelf placement @ closing bell. I took my profits. Very common after all the recent upgrades.
👍️0
investor86 investor86 6 years ago
Congrat$$$
👍️0
BAD HEMPER BAD HEMPER 6 years ago
I’m up $30 a share on this bad boy. Loving the action here.
👍️0
crudeoil24 crudeoil24 6 years ago
Agree! > TNDM is a great $$$$$ opportunity.
👍️0
crudeoil24 crudeoil24 6 years ago
Bank of America has $45. PT. Several other recent upgrades .
👍️0
crudeoil24 crudeoil24 6 years ago
TNDM strong, surpassing targets!
👍️0
BAD HEMPER BAD HEMPER 6 years ago
Bought this at $10. First post here on this board since I have been back on Ihub. This is a true gamer. I think we go much higher in the future. $50 plus
👍️0
joanne4trade joanne4trade 6 years ago
Great stock to invest in. The average stock price, volume and product growth are all helping with the bullish trend. Leading indicators predicted a long term trend at the beginning of April for the TNDM stock. #BluSignals

https://www.blusignalsystems.com/why-tndm-stock-surged-leading-indicator-predictions/
👍️0
rocknroll350 rocknroll350 6 years ago
This thing is like the energizer bunny.. just an epic run
👍️0
alanjb alanjb 6 years ago
Huge news for TNDM and DXCM.... this should drive t:slim pump adoption. Continuous Glucose Monitoring dramatically getting improved and should see upside for a long time to come as people using insulin injection convert to pumps, and people on pumps with sensors or finger sticks for calibration get better accuracy as industry gets closer to closed loop systems.

https://www.businesswire.com/news/home/20180621006260/en/Tandem-Diabetes-Care-Announces-FDA-Approval-

Only four major stand-alone Diabetes device companies left; TNMD, DXCM, PODD and MDT. Also ABT.
👍️0
TheFinalCD TheFinalCD 6 years ago
Oppenheimer analyst Steven Lichtman maintained a Buy rating on Tandem Diabetes (NASDAQ: TNDM) today and set a price target of $24. The company’s shares closed yesterday at $20.31, close to its 52-week high of $21.50.


http://www.analystratings.com/articles/oppenheimer-sticks-to-its-buy-rating-for-tandem-diabetes/
👍️0
TeddyCaswell TeddyCaswell 6 years ago
25$ tommorrow at the open
👍️0
MaineMan5 MaineMan5 6 years ago
Update on TNDM below...... not mentioned in the article is that I think TNDM is due a decision on Canada distribution by May 6 at the latest. Could be another catalyst coming up shortly here.

https://seekingalpha.com/article/4164371-pivotal-point-tandem-diabetes-care

👍️0
Klinsmann Klinsmann 6 years ago
Really? After 200% gains?!? Expect it to settle, first day it´s losing some steam. Good to see it rise steadily day by day during the last weeks, setback gonna be healthy right now.
👍️0
Woody Driver Woody Driver 6 years ago
Short squeeze coming.
👍️0
INTL INTL 6 years ago
Still rocking AH. Never saw a weakness in this one to short. Good Luck.
👍️0
MaineMan5 MaineMan5 6 years ago
I'm a long only guy, but I would think there are much better companies out there to short than this one right now. TNDM just released good preliminary numbers, has a couple catalysts on horizon, and seems to be gaining visibility as evidenced by increasing volume the last two months. Yes, it is overbought right now by just about every measure, but that doesn't mean it can't go higher, or it gets another big pop with an announcement of some kind. JMO of course. GL.
👍️0
Longer Than Most Longer Than Most 6 years ago
Wowza major reversal finally in place here
👍️0
INTL INTL 6 years ago
Hard to gauge this one. Would like to short.
👍️0
ClayTrader ClayTrader 6 years ago
* * $TNDM Video Chart 03-27-18 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 6 years ago
* * $TNDM Video Chart 03-02-18 * *

Link to Video - click here to watch the technical chart video

👍️0
irisku irisku 6 years ago
Scandinavia and Canada now. Two areas to enlarge commercial sales. Hope it will give a positive result finally
👍️0

Your Recent History

Delayed Upgrade Clock